You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
|
|---|---|
| Published in |
BMC Cancer, May 2019
|
| DOI | 10.1186/s12885-019-5675-4 |
| Pubmed ID | |
| Authors |
Anna Dorothea Wagner, Heike I. Grabsch, Murielle Mauer, Sandrine Marreaud, Carmela Caballero, Peter Thuss-Patience, Lothar Mueller, Annelie Elme, Markus Hermann Moehler, Uwe Martens, Yoon-Koo Kang, Sun Young Rha, Annemieke Cats, Masanori Tokunaga, Florian Lordick |
Mendeley readers
The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 159 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 18 | 11% |
| Researcher | 17 | 11% |
| Student > Postgraduate | 15 | 9% |
| Other | 14 | 9% |
| Student > Ph. D. Student | 14 | 9% |
| Other | 37 | 23% |
| Unknown | 44 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 74 | 47% |
| Nursing and Health Professions | 9 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
| Agricultural and Biological Sciences | 3 | 2% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Other | 10 | 6% |
| Unknown | 54 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2023.
All research outputs
#7,922,551
of 23,862,416 outputs
Outputs from BMC Cancer
#2,172
of 8,543 outputs
Outputs of similar age
#138,607
of 352,654 outputs
Outputs of similar age from BMC Cancer
#65
of 211 outputs
Altmetric has tracked 23,862,416 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,543 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,654 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 211 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.